|
|
|
Volumn 157, Issue 2, 2001, Pages
|
|
Alzheimer's disease. New insights into its cause lead to new drug strategies.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
PROTEINASE;
PROTEINASE INHIBITOR;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
PHARMACOGENETICS;
SYNTHESIS;
UNITED STATES;
AGED;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
DRUG DESIGN;
ENDOPEPTIDASES;
HUMANS;
PHARMACOGENETICS;
PROTEASE INHIBITORS;
UNITED STATES;
|
|
EID: 0035864113
PISSN: 0040781X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
